Alpha v integrins as receptors for tumor targeting by circulating ligands - PubMed (original) (raw)
Alpha v integrins as receptors for tumor targeting by circulating ligands
R Pasqualini et al. Nat Biotechnol. 1997 Jun.
Abstract
Phage displaying an Arg-Gly-Asp (RGD)-containing peptide with a high affinity for alpha v integrins homed to tumors when injected intravenously into tumor-bearing mice. A substantially higher amount of alpha v-directed RGD phage than control phage was recovered from malignant melanomas and breast carcinoma. Antibodies detected the alpha v-directed RGD phage in tumor blood vessels, but not in several normal tissues. These results show that the alpha v integrins present in tumor blood vessels can bind circulating ligands and that RGD peptides selective for these integrins may be suitable tools in tumor targeting for diagnostic and therapeutic purposes.
Comment in
- Addressing tumor blood vessels.
Folkman J. Folkman J. Nat Biotechnol. 1997 Jun;15(6):510. doi: 10.1038/nbt0697-510. Nat Biotechnol. 1997. PMID: 9181567 No abstract available.
Similar articles
- Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Haubner R, et al. J Nucl Med. 2001 Feb;42(2):326-36. J Nucl Med. 2001. PMID: 11216533 - Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.
DeNardo SJ, Burke PA, Leigh BR, O'Donnell RT, Miers LA, Kroger LA, Goodman SL, Matzku S, Jonczyk A, Lamborn KR, DeNardo GL. DeNardo SJ, et al. Cancer Biother Radiopharm. 2000 Feb;15(1):71-9. doi: 10.1089/cbr.2000.15.71. Cancer Biother Radiopharm. 2000. PMID: 10740655 - Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, Stöcklin G, Schwaiger M. Haubner R, et al. J Nucl Med. 1999 Jun;40(6):1061-71. J Nucl Med. 1999. PMID: 10452325 - Integrins as targets of angiogenesis inhibition.
Westlin WF. Westlin WF. Cancer J. 2001 Nov-Dec;7 Suppl 3:S139-43. Cancer J. 2001. PMID: 11779085 Review. - Adhesion molecules in melanoma--more than just superglue?
Mason MD, Allman R, Quibell M. Mason MD, et al. J R Soc Med. 1996 Jul;89(7):393-5. doi: 10.1177/014107689608900710. J R Soc Med. 1996. PMID: 8774538 Free PMC article. Review.
Cited by
- Genetically engineered bacteriophages as novel nanomaterials: applications beyond antimicrobial agents.
Kim SM, Heo HR, Kim CS, Shin HH. Kim SM, et al. Front Bioeng Biotechnol. 2024 Apr 25;12:1319830. doi: 10.3389/fbioe.2024.1319830. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38725991 Free PMC article. Review. - Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.
Nhàn NTT, Yamada T, Yamada KH. Nhàn NTT, et al. Int J Mol Sci. 2023 Aug 18;24(16):12931. doi: 10.3390/ijms241612931. Int J Mol Sci. 2023. PMID: 37629112 Free PMC article. Review. - Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.
Ahmadi SE, Shabannezhad A, Kahrizi A, Akbar A, Safdari SM, Hoseinnezhad T, Zahedi M, Sadeghi S, Mojarrad MG, Safa M. Ahmadi SE, et al. Biomark Res. 2023 Jun 6;11(1):60. doi: 10.1186/s40364-023-00504-6. Biomark Res. 2023. PMID: 37280670 Free PMC article. Review. - Anti-angiogenic collagen IV-derived peptide target engagement with αvβ3 and α5β1 in ocular neovascularization models.
Lima E Silva R, Mirando AC, Tzeng SY, Green JJ, Popel AS, Pandey NB, Campochiaro PA. Lima E Silva R, et al. iScience. 2023 Jan 30;26(2):106078. doi: 10.1016/j.isci.2023.106078. eCollection 2023 Feb 17. iScience. 2023. PMID: 36844452 Free PMC article. - Comparative Evaluation of Reproducibility of Phage-Displayed Peptide Selections and NGS Data, through High-Fidelity Mapping of Massive Peptide Repertoires.
Petry KG, Pilalis E, Chatziioannou A. Petry KG, et al. Int J Mol Sci. 2023 Jan 13;24(2):1594. doi: 10.3390/ijms24021594. Int J Mol Sci. 2023. PMID: 36675109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical